SEC Form 4 · accession 0001213900-15-000492
TIANYIN PHARMACEUTICAL CO., INC. · TPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Jiayuan Tong
Officer — CFO & Director & CBDO · Director
Period of report
May 28, 2014
Accepted (ET)
Jan 22, 2015 · 5:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001362718
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 28, 2014 | P | 2,930 | $0.75 | A | 351,136 | D | |
| Common StockF2 | May 28, 2014 | P | 2,930 | $0.75 | A | 354,066 | D | |
| Common StockF3 | Dec 15, 2014 | A | 50,000 | $0.00 | A | 404,066 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On May 28, 2014, Lei Ma transferred 2,930 shares of our common stock to Dr. James Jiayuan Tong at a price of $0.75 per share.
- F2On May 28, 2014, Chunhai Bao transferred 2,930 shares of our common stock to Dr. Tong at a price of $0.75 per share.
- F3In December 2014, our Board of Directors resolved to issue 50,000 shares of our restricted common stock to Dr. Tong as incentive compensation for his service as the Chief Financial Officer in calendar year 2014.
Remarks
On December 31, 2014, Dr. Tong tendered his resignation as the Chief Financial Officer and Director of the Company. On January 5, 2015, the Company accepted Dr. Tong's resignation, effectively immediately.